Mixed Neuroendocrine Non-Neuroendocrine Tumor (MINEN) of the Liver: Report of Two Cases and Review of the Literature.

IF 1.1 Q4 PATHOLOGY
Basharat Mubeen, Malini Eapen, S Sudhindran, Nikhil Krishna Haridas
{"title":"Mixed Neuroendocrine Non-Neuroendocrine Tumor (MINEN) of the Liver: Report of Two Cases and Review of the Literature.","authors":"Basharat Mubeen, Malini Eapen, S Sudhindran, Nikhil Krishna Haridas","doi":"10.5146/tjpath.2024.13492","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To highlight two cases mixed neuroendocrine non-neuroendocrine tumors (MINEN) of the liver and to review the literature till date. To present two cases of MINEN of the liver diagnosed in our centre with clinical & diagnostic workup, the treatment modalities, and follow up. Extensive review of the literature and compilation of the presentation and treatment modalities used in those cases.</p><p><strong>Case reports: </strong>Thirty-three cases of MINEN of the liver have been reported till date including ours. Our cases presented as incidental masses in liver during workup for other symptoms. AFP levels were normal in both cases but PIVKA (Protein induced by vitamin K absence) levels were increased. Resection was done in one of the cases while the other patient had to undergo transplantation. A diagnosis of MINEN was made on H&E, and confirmed on IHC. One patient was unfit for systemic chemotherapy whereas the other patient received cisplastin and etoposide based chemotherapy. Both patients developed metastasis on follow up but are still alive after 12-15 months.</p><p><strong>Conclusion: </strong>MINEN is an uncommon tumor of the liver with a poor prognosis as shown by the few studies available. Recurrence and distant metastases are often described even after complete resection and the course is fatal. The role of adjuvant chemotherapy following surgical resection is not fully elucidated. Mean survival in the cases reported ranged from 1 month to 33 months. However, no significant differences were seen in the clinicopathologic profile of the cases described so far. Further multiinstitutional studies and follow up will help to further characterize this subtype for appropriate treatment.</p>","PeriodicalId":45415,"journal":{"name":"Turkish Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5146/tjpath.2024.13492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To highlight two cases mixed neuroendocrine non-neuroendocrine tumors (MINEN) of the liver and to review the literature till date. To present two cases of MINEN of the liver diagnosed in our centre with clinical & diagnostic workup, the treatment modalities, and follow up. Extensive review of the literature and compilation of the presentation and treatment modalities used in those cases.

Case reports: Thirty-three cases of MINEN of the liver have been reported till date including ours. Our cases presented as incidental masses in liver during workup for other symptoms. AFP levels were normal in both cases but PIVKA (Protein induced by vitamin K absence) levels were increased. Resection was done in one of the cases while the other patient had to undergo transplantation. A diagnosis of MINEN was made on H&E, and confirmed on IHC. One patient was unfit for systemic chemotherapy whereas the other patient received cisplastin and etoposide based chemotherapy. Both patients developed metastasis on follow up but are still alive after 12-15 months.

Conclusion: MINEN is an uncommon tumor of the liver with a poor prognosis as shown by the few studies available. Recurrence and distant metastases are often described even after complete resection and the course is fatal. The role of adjuvant chemotherapy following surgical resection is not fully elucidated. Mean survival in the cases reported ranged from 1 month to 33 months. However, no significant differences were seen in the clinicopathologic profile of the cases described so far. Further multiinstitutional studies and follow up will help to further characterize this subtype for appropriate treatment.

肝脏非神经内分泌混合瘤(MINEN):两例病例报告及文献综述。
目的:重点介绍两例肝脏混合性神经内分泌非神经内分泌肿瘤(MINEN),并回顾迄今为止的文献。介绍本中心确诊的两例肝脏 MINEN 病例,包括临床诊断、治疗方法和随访。广泛回顾文献,汇编这些病例的表现和治疗方法:迄今为止,包括我们的病例在内,已有 33 例肝脏 MINEN 病例被报道。我们的病例是在检查其他症状时偶然发现的肝脏肿块。两个病例的 AFP 水平均正常,但 PIVKA(维生素 K 缺乏引起的蛋白质)水平升高。其中一名患者进行了切除手术,另一名患者则不得不接受移植手术。H&E 诊断为 MINEN,IHC 确诊为 MINEN。一名患者不适合接受全身化疗,另一名患者则接受了以顺磷酸盐和依托泊苷为基础的化疗。两名患者在随访中均出现转移,但在 12-15 个月后仍存活:结论:MINEN 是一种不常见的肝脏肿瘤,现有的少数研究表明其预后较差。结论:MINEN 是一种不常见的肝脏肿瘤,预后较差,现有的研究很少。即使在完全切除后,也经常出现复发和远处转移,而且病程是致命的。手术切除后辅助化疗的作用尚未完全阐明。报告病例的平均生存期从 1 个月到 33 个月不等。不过,迄今为止所描述的病例在临床病理特征方面并无明显差异。进一步的多机构研究和随访将有助于进一步确定该亚型的特征,以便进行适当的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
10.00%
发文量
23
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信